Abstract:Radiation therapy prior to surgery has increasingly become the standard of care for locally advanced prostate cancer, however tumor radioresistance remains a major clinical problem. While restoration of microRNA-145 (miR-145) expression reduces chemoradioresistance in glioblastoma and suppress prostate cancer proliferation, migration and invasion, the role of miR-145 in response to radiation therapy for prostate cancer is still unknown. The aim of this study was to investigate the role of miR-145 in determining the tumor response to radiation treatment in prostate cancer. Human prostate cancer cells LNCAP and PC3 were transfected with miR-145 mimic. Clonogenic assay was used to determine whether overexpression of miR-145 could alter radiation response in vitro. Immunofluorescence of γ-H2AX and flow cytometric analysis of phosphorylated histone H3 were performed to investigate the potential mechanisms contributing to the enhanced radiation-induced cell killing induced by miR-145. In addition, a qPCR-based array was used to detect the possible miR-145-mediated regulated genes involved. Tumor growth delay assays and survival curves were then analyzed in an animal model to investigate whether miR-145 induced radiosensitivity in vivo. Furthermore, miR-145 expression was assessed in 30 prostate tumor tissue biopsies taken prior to neoadjuvant radiotherapy using miRNA arrays. Our current study suggested that ectopic expression of miR-145 significantly sensitized prostate cancer cells to radiation and we used γ-H2AX phosphorylation as a surrogate marker of radiotherapy response versus miR-145 expression levels. We observed significantly more foci per cell in the group treated with miR-145 and radiation. In addition, mitotic catastrophe was significantly increased in cells receiving miR-145 and radiation. The above results suggest that miR-145 appears to reduced the efficiency of the repair of radiation-induced DNA double-strand breaks in cells. A detailed examination of the involvement of the DNA repair pathway showed that miR-145 reduced the expression of 10 genes involved in DNA repair according to a qPCR-based array data. Irradiation of subcutaneous PC3 tumors in mice treated with R11-miR-145 (a cellular permeable peptide, previously reported) resulted in an increase in radiation-induced tumor growth delay and lived the longest after combination treatment. Moreover, miR-145 expression was significantly increased in patients demonstrating good response (PSA < 2.0 ng/ml/year) to neoadjuvant radiotherapy, while expression of the miR-145-regulated DNA repair genes was significantly decreased. In conclusion, these data suggest a possible mechanism for miR-145 radiosensitivity, potentially through down regulating of DNA repair. This novel study shows a role for miR-145 in modulating radiosensitivity in vivo and highlights the need for further study investigating the potential role of miR-145 as both a predictive marker of response and a novel therapeutic agent with which to enhance the efficacy of radiation therapy.

MiR-145 Modulates the Radiosensitivity of Non-Small Cell Lung Cancer Cells by Suppression of TMOD3.

Mir-144-5p Enhances The Radiosensitivity Of Non-Small-Cell Lung Cancer Cells Via Targeting Atf2

MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer

Mir-410 Induces Both Epithelial–mesenchymal Transition and Radioresistance Through Activation of the PI3K/mTOR Pathway in Non-Small Cell Lung Cancer

MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR

MiR-365 enhances the radiosensitivity of non-small cell lung cancer cells through targeting CDC25A.

Downregulation of High Mobility Group Box 1 Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Acting As a Crucial Target of Microrna-107

Radiosensitization effect of hsa-miR-138-2-3p on human laryngeal cancer stem cells.

Mechanism Of Mir-512-5p To Promote Radiotherapy Sensitivity Of Lung Cancer By Targeting Sod2

MiR-147a Mediated by Sodium New Houttuyfonate Could Enhance Radiosensitivity of Non-Small Cell Lung Cancer Cells Via Suppressing STAT3.

Downregulation of miR-423-5p Contributes to the Radioresistance in Colorectal Cancer Cells

Aberrant Mir-1246 Expression Promotes Radioresistance in Non-Small Cell Lung Cancer: a Potential Prognostic Biomarker and Radiotherapy Sensitization Target.

Up-regulation of microRNA153 causes radio-sensitization of lung cancer cells in vitro experiments

Progress on the Relationship Between Mirna and Lung Cancer in Radiosensitivity

MicroRNA-9 Enhanced Radiosensitivity and Its Mechanism of DNA Methylation in Non-Small Cell Lung Cancer

Ectopic Expression of Mir-34A Enhances Radiosensitivity of Non-Small Cell Lung Cancer Cells, Partly by Suppressing the LyGDI Signaling Pathway.

Downregulation of Mir-1 in Colorectal Cancer Promotes Radioresistance and Aggressive Phenotypes.

Mir-205 Acts As a Tumour Radiosensitizer by Targeting ZEB1 and Ubc13

Mir-30A Radiosensitizes Non-Small Cell Lung Cancer by Targeting ATF1 That is Involved in the Phosphorylation of ATM.

Regulation of miRNAs affects radiobiological response of lung cancer stem cells.

Role and Mechanism of Mir-4778-3p and Its Targets NR2C2 and Med19 in Cervical Cancer Radioresistance.